Koers DSM-Firmenich AG Wiener Boerse
Aandelen
RDSM
NL0000009827
consumenten goederen conglomeraten
Omzet 2024 * | 12,63 mld. 13,58 mld. | Omzet 2025 * | 13,3 mld. 14,3 mld. | Marktkapitalisatie | 28,11 mld. 30,22 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 452 mln. 486 mln. | Nettowinst (verlies) 2025 * | 781 mln. 840 mln. | EV/omzet 2024 * | 2,45 x |
Nettoschuld 2024 * | 2,85 mld. 3,06 mld. | Nettoschuld 2025 * | 2,58 mld. 2,78 mld. | EV/omzet 2025 * | 2,31 x |
K/w-verhouding 2024 * |
60,8
x | K/w-verhouding 2025 * |
35,2
x | Werknemers | 28.685 |
Dividendrendement 2024 * |
2,31% | Dividendrendement 2025 * |
2,34% | Vrij verhandelbaar | 25,03% |
Recentste transcriptie over DSM-Firmenich AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-01-90 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 01-09-23 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-02-23 | |
Thomas Leysen
CHM | Chairman | 63 | 01-02-23 |
Director/Board Member | 62 | 01-02-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,38% | 239 mld. | |
+32,86% | 185 mld. | |
-6,30% | 128 mld. | |
+39,58% | 88 mld. | |
-5,82% | 73,75 mld. | |
-12,90% | 52,87 mld. | |
+40,90% | 38,61 mld. | |
-25,53% | 38,11 mld. | |
+61,08% | 31,15 mld. |